ALDH18A1 and metabolic dysfunction-associated steatotic liver disease: However, another study by Zhang et al. showed significantly poorer performance of GPR compared to TE for the prediction of F4 (P < 0.05) in patients with CHB concurrent with nonalcoholic fatty liver disease (NAFLD) [20].